Also known as LY3437943 , Retatrutide is an investigational triple hormone receptor agonist that activates three major metabolic pathways: GIP (Glucose-Dependent Insulinotropic Polypeptide) , GLP-1 (Glucagon-Like Peptide-1) , and glucagon receptors
The trial was designed to fulfill the US Food and Drug Administration (FDA) requirement that diabetes medication prove cardiovascular safety prior to approval
In its active form it protects us from free radicals and the damage they can inflict on our cells and DNA
With CellTox Green Dye present, there was no significant difference in total glutathione levels detected, indicating no adverse effect of multiplexing these two assays (compare green and gray bars, Figure 5, Panel B)
These could include symptoms such as itching, a rash/hives, swelling especially around the face or throat, or difficulty breathing
Research shows that pregnant women with enough vitamin B12 have fewer pregnancy complications